The Claim
In adults with schizophrenia and metabolic syndrome on antipsychotic medication, adjunctive administration of berberine at 600 mg/day for 12 weeks reduces body mass index by 0.41 kg/m² compared to placebo, with a large effect size (d=0.64), indicating significant improvement in overall adiposity.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with schizophrenia and metabolic syndrome taking antipsychotic drugs, taking 600 mg of berberine daily for 12 weeks lowers body mass index by 0.41 kg/m² compared to a placebo, reflecting a measurable reduction in body fat.
See the scientific wording
In adults with schizophrenia and metabolic syndrome on antipsychotics, adjunctive berberine (600 mg/day for 12 weeks) reduces body mass index by 0.41 kg/m² compared to placebo, with a large effect size (d=0.64), indicating significant improvement in overall adiposity.
Berberine triggers a cellular energy sensor that turns off fat production and turns on fat burning and sugar uptake in muscles, causing the body to store less fat and lose weight.
What the research says
1 studyIn a study, people with schizophrenia and weight problems who took 600 mg of berberine daily for 12 weeks lost a small but noticeable amount of body fat (measured by BMI) compared to those who took a sugar pill — and it didn’t make their mental health worse.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.